Evidence map›Paper›PMID 31320631›Full record

ArticleNature communications2019

Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface.

HaoRan Tang, Leo Leung, Grazia Saturno, Amaya Viros, Duncan Smith, Gianpiero Di Leva, Eamonn Morrison, Dan Niculescu-Duvaz, Filipa Lopes, Louise Johnson and 3 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

HaoRan TangMolecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK.
Leo LeungGene and Oncogene Targeting Team, CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Grazia SaturnoMolecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK.
Amaya VirosMolecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK.
Duncan SmithBiological Mass Spectrometry Unit, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK.
Gianpiero Di LevaMolecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK.
Eamonn MorrisonMolecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK.
Dan Niculescu-DuvazGene and Oncogene Targeting Team, CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Filipa LopesGene and Oncogene Targeting Team, CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Louise JohnsonGene and Oncogene Targeting Team, CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Nathalie DhomenMolecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK.
Caroline SpringerGene and Oncogene Targeting Team, CRUK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK. caroline.springer@icr.ac.uk.
Richard MaraisMolecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, UK. richard.marais@cruk.manchester.ac.uk.
University of Manchester · GBInstitute of Cancer Research · GBCancer Research UK Manchester Institute · GB

Funding

Cancer Research UK 17240Cancer Research UK 19279Cancer Research UK 22902
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31320631
PMCPMC6639354
OpenAlexW2956284213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.